To this end, we have now planned preclinical studies to evaluate the in vivo efficacy of murine GAMT-MAT-loaded RBCs in a mouse model of GAMT deficiency. The gene discussed is GAMT; the disease is hyperinsulinemic hypoglycemia, familial, 4.